Etiological Factors of Obesity-Associated Hyperandrogenemia in Peripubertal Girls

NCT00928759 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2022-05-18

No results posted yet for this study

Summary

The purpose of this study is to learn if obese pre- and early pubertal girls with hyperandrogenemia (HA) are more insulin resistant (i.e., have lower insulin-stimulated glucose disposal) compared to obese peripubertal girls without HA; and that overnight mean luteinizing hormone (LH) concentration is also an independent predictor of free testosterone concentrations, especially in mid- to late pubertal girls.

Conditions

  • Obesity
  • Hyperandrogenemia
  • Polycystic Ovary Syndrome

Sponsors & Collaborators

  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

    collaborator NIH
  • University of Virginia

    lead OTHER

Principal Investigators

  • Christopher McCartney, MD · University of Virginia

Eligibility

Min Age
8 Years
Max Age
16 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-03-31
Primary Completion
2023-05-31
Completion
2023-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00928759 on ClinicalTrials.gov